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and psychiatric conditions may be more likely to 
manage patients with different causes of halitosis than 
any other dental specialty. The present report reviews 
halitosis and its implications in special care dentistry.
Origins and causes of bad breath
in special care patients 
The oral cavity is an important part of both digestive 
and respiratory systems, therefore the possible 
causes of halitosis are conditions where oral, upper 
and lower respiratory tract, digestive system, and 
diseases play a role on producing volatile compounds 
released in exhaled air with an unpleasant smell (7, 
13–17). Special care patients (SCP) are prone to have 
halitosis, as the majority of them may have primary 
or secondary systemic conditions that might be the 
cause of oral malodor (Table 1). Diet, medications, 
some psychological and psychiatric as well as 
neurological disorders may also be the source of this 
problem in SCP.
Intra-oral causes
The most common source of halitosis is the oral 
cavity. A recent study conducted in Belgium on 2,000 
patients found that an intra-oral cause accounted for 
Introduction
Oral malodor, foetor ex ore, bromopnea or, more 
commonly, halitosis are generic terms used to identify 
a disagreeable odor emanating from the oral cavity 
and breath. Halitosis can affect all people regardless 
of gender and age (1, 2). Epidemiological data reveal 
that 50% of the population may have this problem, and 
in a few cases subjects may experience psychological 
and social repercussions (3–5). In the majority of 
patients halitosis has oral causes, but in some cases it 
may have either extra-oral causes related to systemic 
diseases, often called “blood borne halitosis”, or 
infections of the upper respiratory tract (6). Although 
halitosis often refers to a persistent condition which 
requires diagnosis and treatment, it can also be just 
a transient problem caused by particular diet, drugs, 
and habits (7–10). Also, a psychogenic disease 
termed pseudohalitosis or halitophobia also exists: 
patients affected by this disorder, despite having no 
objective evidence of oral malodor, strongly believe 
they have halitosis (4, 5, 11, 12).
In the last few years dentistry has seen a rising interest 
on halitosis due to increasing individual consideration 
and self-esteem of the patients. Special care dentists 
treating patients affected from disabilities, systemic 
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Epidemiological studies report that about 50% of the population may have oral malodor 
with a strong social and psychological impact in their daily life. When intra-oral causes are 
excluded, referral to an appropriate medical specialist is paramount for management and 
treatment of extra-oral causes. The intra-oral causes of halitosis are highly common, and the 
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dentistry.
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the halitosis of 76% of the examined subjects (11). 
The oral surfaces are colonized by a large number of 
different species of bacteria which are able to produce 
malodorous substances (18, 19). Gram-negative 
anaerobic proteolytic bacteria are potent producers of 
malodour compounds and comprise Porphyromonas 
gingivalis, Porphyromonas endodontalis, Prevotella 
melaninogenica, Prevotella intermedia, Treponema 
denticola, Bacteroides loescheii, Eikenella corrodens, 
Bacteroides forsythus, Centipeda periodontii, 
Special Care category
Physical impairment
Cerebral palsy
Stroke
Traumatic injuries to CNS
Arthritis
Elderly people
Amputated patients
Multiple sclerosis
Parkinson’s disease
Muscular dystrophy
Intellectual impairment
Psychiatric disorders
Anxiety disorders
Dental phobia
Down’s syndrome
Autism spectrum disorders
Forms of dementia
Medically compromised patients
 
Respiratory diseases
Foreign body (nose/lung)
Sinusitis
Tonsillitis
Malignancy
Bronchiectasis
Tuberculosis
Tonsilloliths
Obsctructions
Gastrointestinal and hepatic disease
Helicobacter pylori infection
GERD
Hiatus hernia
Zenker diverticulum
Pharingeal pouch
Hepatic failure
Renal disease End stage renal failure 
Metabolic diseases TrimethylaminuriaHypermethioninemia
 Endocrine Poorly controlled diabetes
Chemically dependent and drugs
 Chemicals
Tobacco
Alcohol
Betel
Solvent abuse
Drugs
Nitrites and nitrates
Dimethyl sulphoxide
Disulphiram
Some cytotoxics
Phenothiazines
Amphetamines
Suplatast tosilate
Paraldehyde
Long stay institutions
Prolonged hospitalization
Institutionalized patients
Homebound subjects
Table 1 Patients with special needs who may be at of risk of halitosis
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Fusobacterium nucleatum, Fusobacterium nucleatum 
polymorphum, Fusobacterium periodonticum and 
Veillonella alcalescens (14, 20–24).
Major metabolic bacteria compounds that contribute 
to oral malodor are volatile sulfur compounds (VSCs) 
such as hydrogen sulfide (H2S), methyl mercaptan 
(CH3SH), and dimethyl sulfide (CH3SCH3) (18, 25, 
26). Short chain fatty acids, such as propionic acid 
and butyric acid, cadaverin, indole, and skatole have 
also been reported to account for the source of the 
malodor (1, 27). The tongue and periodontal pockets 
are the main sites for production of VSCs dependent 
on a fast bacterial degradation activity of organic 
substrates from either endogenous or dietary origin 
(20, 21, 26, 28). Poor oral hygiene with accumulation 
of food debris and bacteria plaque on teeth and 
gingivae leads to gingivitis, necrotizing ulcerative 
gingivitis and periodontal disease (Xu et al., 2014), 
which reflect a pathological increase in the number of 
bacteria responsible for halitosis. Pericoronitis, peri-
implantitis, prosthetic appliances, dry socket, oral 
mucosal infections, xerostomia, mouth ulcers and 
oral cancer may also cause malodor (7, 8, 16, 18, 
29). Physically and intellectually impaired patients 
may have oral pathologies, often due to poor oral 
hygiene compliance or as result of the side effect of 
medications. 
Sjögren’s syndrome, diabetes (16), HIV, Crohn’s 
disease, sarcoidosis, anemia, are examples of 
conditions that have oral manifestations which may 
lead to intra-oral halitosis in SCP. 
Xerostomia is frequent among elderly patients, 
especially when homebound or institutionalized. 
This has been associated with the high number of 
their concomitant medications, where cardiovascular 
and psychiatric drugs are the most significant (30). 
During sleep, the proliferation of oral microorganisms 
associated with nocturnal hypo-salivation is 
responsible for the production of VSCs with resulting 
morning bad breath even in otherwise healthy subjects 
(28). However a study conducted in the Netherlands 
concluded that morning halitosis is only a transient 
phenomenon that often disappears in the late morning 
even without direct oral hygiene (31).
Extra-oral and systemic causes
Medically compromised patients are the largest 
category of patients treated in special care clinics. In 
these patients, frequent extra-oral causes of halitosis 
can be disorders of the upper, and to a lesser degree, 
lower respiratory tract. Acute and chronic infections 
of both the upper and the lower respiratory tract 
such as recurrent tonsillitis, sinusitis, bronchiectasis, 
have been reported as causes of malodor (2, 11, 
32). Other airway conditions capable of generating 
bad breath may be pharyngeal ulceration, post-
tonsillectomy eschar, tuberculosis, ENT malignancies 
as well as foreign body in the nose or in the lungs 
(6, 8). Obstructions due to anatomical deformities 
or infections may create conditions for oral breath, 
leading to dry mouth as a potential cause of halitosis 
(33). Indeed patients with Down’s syndrome may 
easily develop oral malodor, since they have a high 
incidence of respiratory infections and are susceptible 
to oral breathing (34). In contrast, no difference in 
VSCs level has been found between patients with 
repaired cleft palate and those without cleft, as long 
as the oral hygiene is controlled (35). Tonsilloliths, 
occurring as a result of chronic inflammation of the 
tonsils when debris calcifies in the crypts, have been 
proven to be a possible cause of unpleasant smell 
(36).
Although the gastrointestinal tract is not a common 
source of halitosis, a study carried out in Israel on 
94 patients complaining of halitosis, found that 57% 
had upper gastrointestinal disorders and following 
the treatment halitosis improved in most of the 
patients (37). The production of VSCs has been 
strongly associated to Helicobacter pylori in patients 
with functional dyspepsia and its eradication can 
contribute to a rapid resolution of halitosis (17, 38, 
39). Helicobacter pylori has also been detected in the 
saliva and periodontal pockets, identifying the oral 
cavity as a possible reservoir for such bacteria (40). 
Gastroesophageal reflux disease (GERD), the latter 
stage of Zenker diverticulum, and hiatus hernia have 
each been reported as a source of increased VSCs 
(41, 42). A significant association between GERD, 
BMI, and obesity has been found; for that reason 
bariatric patients may be at risk of extra-oral halitosis 
(30). At present, there is no reliable evidence to 
suggest that lower gastrointestinal tract disease gives 
rise to halitosis.
Liver diseases such as viral hepatitis, alcoholic 
hepatitis, and cirrhosis can be important causes of 
oral malodor. Dimethyl sulfide, acetone, 2-pentanone 
and 2-butanone have been identified in high levels 
in alveolar air patients with various degrees of 
hepatocellular failure and portosystemic shunting of 
blood, explaining sometimes the altered breath smell 
of individuals with liver conditions (foetor hepaticus) 
(43). Acetone is also responsible for the sweet “fruity” 
breath of patients with diabetes mellitus, and may 
be a strong indicator of high blood glucose in poorly 
controlled diabetes (16,44,45). Haemodialysis seems 
to help decreasing the uremic bad breath caused 
by high urea hydrogen levels in saliva of patients 
suffering from end stage renal disease (44,46). 
Trimethylaminuria is a rare metabolic disorder that 
leads to an increased level of trimethylamine in 
the patients sweat, urine, and breath giving off a 
characteristic tough fishy breath and body odor which 
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strongly distresses subjects (47). Hypermethioninemia 
is another rare genetic metabolic disease, caused 
by a deficiency in the enzymes that break down 
methionine, where the breath of the patient may have 
a strong smell resembling boiled cabbage (48).
Food and drugs
A large number of volatile food products and 
drugs can give rise to halitosis. Although some foods 
objectively give rise to an unpleasant breath odor, some 
individuals and several communities do not accept the 
term of halitosis when associated with certain foods 
such as garlic, onion, and spices since this is a normal 
part of their culture (8). The same consideration can be 
made for areca nut (betel nut) as chewed by more than 
600 million people from Indian subcontinent, south 
Asia, and Melanesia. A study from India demonstrated 
that areca nut chewers are more prone to halitosis as 
well as periodontal conditions than non-chewers. The 
study did not explain whether the halitosis is caused by 
areca nut itself or it is a direct consequence of the poor 
periodontal status and oral ulcers induced by the use of 
this particular drupe (49).
There is weak evidence that chronic alcohol 
consumption is an independent cause of halitosis. 
The capacity of alcohol to generate oral malodor 
seems to be more related to a low saliva flow rate and 
periodontal disease than the volatile acetaldehyde 
excreted by the lungs (50). 
Tobacco smoking as an independent factor of 
oral malodor is also controversial, and needs further 
investigations to determine whether the VSCs increase 
in the mouth of smokers (7).
A wide range of drugs can give rise to altered 
breath smell, including disulphiram, phenothiazines, 
paraldehyde, amphetamines, nitrites and nitrates, 
chloral hydrate, and some cytotoxic drugs are most 
acknowledged to be a direct cause of bad breath (8, 
32).
Pseudohalitosis and halitophobia
Pseudohalitosis refers to patients who complain 
of having oral malodor (that objectively does not 
exist) which is often accompanied (or leads to) 
by significant avoidance of social situations. If 
after oral hygiene, reassurance, and psychological 
treatment the complaint continues, it is considered as 
halitophobia (5). An epidemiological study has shown 
that this phenomenon, previously considered very 
rare, may affect 16% of all patients attending halitosis 
clinics. The disorder seems to be more common in 
women than men (11). Frequently these patients are 
misdiagnosed by dentists and over treated for dental 
or periodontal problems. Moreover, often they receive 
unnecessary and expensive diagnostic and surgical 
procedures such as gastroscopies and tonsillectomies 
resulting from incorrect diagnosis and referrals. Of 
relevance to this problem, a German survey revealed 
that 41% of dentists consider the stomach as a 
principal cause of oral malodour (51).
It has been suggested that patients with 
pseudohalitosis and halitophobia may fall within the 
spectrum of social anxiety disorder, whereas oral 
malodor may represent a symptom of psychiatric 
conditions such as olfactory reference syndrome 
(ORS), obsessive compulsive disorder (OCD), body 
dysmorphic disorder (BDD) (4, 5, 8, 12, 52).
Olfactory dysfunctions associated to neurodegenerative 
disorders may cause delusional halitosis, indeed 
parosmia and phantosmia episodes may occur in 
Parkinson’s disease, Alzheimer’s type dementia, and 
multiple sclerosis (53). Olfactory hallucinations are 
also common in schizophrenic patients, and may arise 
during epileptic or migranous aura (54).
Diagnosis of halitosis
The relationship between oral malodor, oral and 
extra-oral causes, lifestyle, habits are crucial (9,15,55). 
Therefore a detailed medical and social history as well 
as an extensive oral examination is essential during 
the diagnostic process (56, 57).
Although sometimes the diagnosis of halitosis 
may be made by other medical specialists such as 
ENT specialists or gastroenterologists, dentists are 
likely to be the most central clinicians  diagnosing 
genuine or pseudo-halitosis (8, 19). Rosemberg, 
suggested setting up special dental appointments for 
the assessment, where the patient has to refrain from 
drinking, eating, chewing, gargling, and smoking for 
at least two hours before the appointment (56). The 
gold standard for objectively assessing the halitosis in 
dental practice is the organoleptic method. The test is 
based on the clinical judgement of the quality of the 
odor and can give useful information on the severity 
of the halitosis, and the health conditions of different 
areas of the oral cavity (35). This method, though, still 
has a certain degree of subjectivity. Therefore, trained 
clinical staff are recommended in order to improve the 
reliability and reproducibility of the test (58).
Patient self-assessment of bad breath is unreliable 
particularly when this is the primary patient complaint 
as cognitive, emotional, psychological and physiological 
factors may interfere with an objective judgement 
(4). For this reason, it is important that the patient 
attends the appointment with a relative or a confidant 
in order to attain a more realistic understanding 
of both extension and severity of the problem (56). 
Conversely, a recent Italian study repoted that 94% of 
patients self-assessed for oral malodor correlated well 
with the organoleptic examination, particularly those 
with slight or moderate halitosis (59).
Commercial portable sulphur detectors are available 
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to estimate chairside the objective intra-oral VSCs 
level. Sulphide monitors (eg. Halimeter) and portable 
gas chromatograph (OralChroma) have a very high 
sensibility and sensitivity in determining the VSCs 
level in the exhaled breath. Nevertheless a recent 
paper reports that there is a good correlation between 
the organoleptic score and sulphur monitors and they 
can be used as an adjunct to the organoleptic score, 
which still has to be considered the gold standard for 
determining the presence of bad breath (58).
Other diagnostic methods are based on identifying 
the presence of bacteria producing VSC’s using 
microbiological methods (dark field microscopy and 
bacteria culture), molecular biology methods (PCR 
and Real time PCR), and detection of trypsin-like 
activities of bacteria (BANA test) are not being used 
routinely in the clinical environment (8,32). Gas and 
liquid chromatography can be used to determine both 
intra oral and extra-oral volatile compounds otherwise 
not detectable by portable devices, but their use 
remains confined principally to research purposes 
(25, 27, 32).
Management 
Extra-oral and systemic causes of halitosis should 
be managed by an appropriate specialist (eg. 
ENT, endocrinology, gastroenterology) for patient 
management and treatment (Table 2).
Intra-oral causes generally are plaque-related; as a 
consequence, adequate home oral hygiene regimen, 
periodical dental check ups, professional oral hygiene, 
and treatment of oral conditions generally improve 
or resolve the halitosis (8). Mechanical plaque 
removal by means of tooth brushing, interdental 
flossing, and possibly tongue scraping, is the most 
effective way to reduce the bacteria VSCs production 
(9,56,60). Chemical reduction of micro-organisms 
can be achieved using mouthrinses and toothpastes 
containing effective antimicrobial agents, such as 
chlorhexidine gluconate, triclosan, cetypyridinium 
chloride, allylpyrocatechol, dehydroascoric acid, 
L-trifluoromethionine (32, 57).
Amine fluoride/stannous fluoride and flavoring 
agents present in toothpastes may be helpful in 
easing morning bad breath via VSCs reduction 
(28, 61, 62). Temporary chemical neutralization of 
odorous compounds by means of mouthwashes and 
toothpastes containing zinc, sodium bicarbonate, 
magnesium, hydrogen peroxide, chlorine dioxide and 
iminium, has been demonstrated to be effective in 
lessening the offensive breath, although the efficacy 
appears to be limited to a few hours (57).
Avoidance of food products which cause altered 
breath smell lessens the halitosis related to dietary 
origin, and the same consideration applies to tobacco 
smoking and alcohol drinking. A recent American 
Table 2 Treatment of halitosis for SCP
Prevention
- Regular dental check ups and clinical reviews
- Homa oral hygiene
Tooth brushing
Dental Flossing
Tongue scrapping
- Oral hygiene instructions to caregivers
Treatment
Management of oral pathologies to reduce VSCs levels
Chemical reduction of  VSCs
Chlorexinine gluconate
Triclosan
Cetypyridinium chloride
Allyloyrocatechol
Trifluoromethionine
Dehydroascorbic acid
Amine fluoride/stannous fluoride
Temporary odour neutralizers (limited a few hours)
Zinc
Sodium bicarbonate
Magnesium
Hydrogen peroxide
Chlorine dioxide
Iminium
Xerostomia management
Saliva substitutes
Citric acid
Chewing gum sugar free
Avoidance of certain foodstuffs, alcohol, and tobacco smoking
Halitophobia warrants referral to clinical psychologist
Extra-oral causes of halitosis require referral to appropriate specialist
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study found that mixing whole milk with garlic before 
the ingestion may help reduce the unpleasant breath 
smell after garlic intake (8, 63).
Masking products such as mints, sprays, and 
chewing gums without active ingredients have no 
significant effect on mouth malodor. On the other hand 
eucalyptus-extract chewing gum has been found to 
have long term effect on VSCs level as well as tongue-
coating score compared to placebo (64).
Pseudohalitosis can be treated by dental 
practitioners, but halitophobic patients must be 
referred to psychological specialists for evaluation 
and treatment of possible underlying mental health 
conditions. Unfortunately, only a very small number 
of these patients are willing to follow this advice, 
and there are no reports of the long term outcomes 
regarding these individuals (32, 65).
Recommendations for special care
dentistry 
Special Care Patients (SCP) who have intellectual 
or physical impairments are at risk of oral malodor, 
as they may not be aware of the necessity, or able, 
to accomplish an effective oral hygiene. Frequently 
caregivers may neglect the provision of normal oral 
hygiene for whom they are responsible as a result of 
poor dental knowledge or because of the disagreeable 
aspects of oral care (66). The same consideration 
applies to patients with chronic, physical and mental 
diseases, or frail elderly people, who may often be 
homebound or may need prolonged hospitalization. 
A recent survey carried out in Nigeria reported a poor 
level of oral health among psychiatric outpatients, 
agreeing with, and supporting, the results of a previous 
Italian study on institutionalized mental health patients 
(67, 68). Therefore instructions to caregivers must be 
given in order to assist SCP to achieve an acceptable 
oral hygiene.
Saliva substitutes or citric acid may help controlling 
the bad breath caused by xerostomia as a result of the 
side effect of several drugs, or when a symptom of a 
systemic or psychological disorder (18, 69, 70).
When the oral causes are excluded the halitosis 
may be a sign of an undiagnosed systemic, 
metabolic, or psychological disorder. Indeed, in the 
past, physicians used to test the patients breath 
for assistance in the clinical diagnosis of systemic 
diseases such as acute leukaemia (71). Thus, 
an accurate analysis of the medical and social 
history of the patient may be helpful to address 
appropriate referrals to different medical specialists 
for investigations and treatment. 
Halitosis among SCP may be a cause of social 
isolation and psychological distress and it may 
strongly interfere in the quality of life of the patient 
(72). Improvement of the bad breath may not only 
result in an improved physical and oral health, but it 
may be also achieve an improvement of psychological 
disturbance, the person being able to socialize with 
others, improving their quality of life.
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